Ivantis

Irvine, United States Founded: 2007 • Age: 19 yrs Acquired By Alcon
Implantable device to relieve intraocular pressure in open angle glaucoma

About Ivantis

Ivantis is a Technology company based in Irvine (United States) founded in 2007, and was acquired by Alcon in November 2021. Implantable device to relieve intraocular pressure in open angle glaucoma. It operates in the Technology and Healthcare sectors. Ivantis has raised $166.23 million across 7 funding rounds from investors including Alcon, RA Capital and Merieux Equity Partners. The company has 132 employees. Its focus areas include Life Sciences, Ophthalmology, Medical Devices and Therapy. Its legal entity is IVANTIS, INC. Its competitors include Glaukos, Myra Vision and Transcend Medical; 3 of its 3 listed competitors have raised funding.

Company details

Ivantis Inc. was founded in 2007 in Irvine, United States, focusing on medical devices for ophthalmology. Solutions for primary open-angle glaucoma are developed by the company, including an intracanalicular scaffold designed as an implantable device. High intraocular pressures in patients are addressed through this technology. Operations center on innovation in glaucoma treatment, with the domain ivantisinc.com serving as the primary online presence.

  • Headquarters Irvine, United States
  • Employees 132
  • Stage Acquired
  • Sectors
    Technology
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website ivantisinc.com
  • Social LinkedIn X
  • Acquired by Alcon (Nov 2021)
  • Legal Name Ivantis, Inc.
Key Metrics
  • Total Equity Funding
    $166.23M (USD)

    in 7 rounds

  • Latest Funding Round
    $25M (USD), Series C

    Jan 2017

  • Investors
    Alcon

    & 10 more

  • Employee Count
    132
  • Acquired by
    Alcon

    (Nov 2021)

Funding Insights of Ivantis

Ivantis has successfully raised a total of $166.23M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $25 million completed in January 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $166.23M
  • Total Rounds 7
  • Last Round Series C β€” $25M
  • First Round $19.1M

    (Jun 2008)

  • Investors Count 10

All 7 funding rounds of Ivantis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2017$25MSeries C–RA Capital Management
Oct 2014$58.87MSeries C–GBS, Vertex Ventures HC
Jan 2014$14MSeries B––
Aug 2013$5MSeries B––
Feb 2013$27MSeries B–Ascension Ventures
May 2011$17.26MSeries B–New Enterprise Associates, Delphi Ventures
–
Jun 2008$19.1MSeries A––
–
Valuation history

11 investors in total: 11 institutional.

Investors in Ivantis

Ivantis has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include Alcon, RA Capital and Merieux Equity Partners.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Pivate equity firm that focuses on investing in healthcare and nutrition companies
merieux-partners.comLyon, France
Venture capital investments are offered to startups by NEA.
nea.comMenlo Park, United States
Investments are made in life sciences firms across all stages.
delphiventures.comMenlo Park, United States
Early & Growth stage life sciences & tech focused VC firm investing primarily in the US
memorialcareinnovationfund.comLong Beach, United States
gbsventures.com.au
Multi-stage investment firm invests in healthcare and life sciences companies
foresitecapital.comNew York, United States
Government-backed investments are directed toward healthcare, fintech, and various sectors.
edbi.comSingapore, Singapore
Strategic investments in healthcare technologies and data innovations.
ascensionventures.org
vertexventureshc.com
RA Capital is engaged in evidence-based investing in healthcare and life sciences.
2004racap.comBoston, United States
Premium access

Investor details for Ivantis

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Ivantis

4 dated milestones of Ivantis across 14 years, from founding to its latest funding, stage changes and deals.

  1. Founded Ivantis is founded.
  2. Funding First funding round of $19.1M.
  3. Funding Latest funding round, Series C, of $25.0M.
  4. Exit Acquired by Alcon.

Competitors of Ivantis

Ivantis has 3 listed competitors in our database, 3 of them funded. They include Glaukos, Myra Vision and Transcend Medical.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
glaukos.com2001Laguna Hills, United States$117.57M907
Developer of implants to treat glaucoma
myravision.com2019Campbell, United States$42M
Nanotechnology-based devices for glaucoma treatment are developed.
transcendmedical.com2006Menlo Park, United States$122.27M20
Minimally invasive glaucoma stents are developed to enhance aqueous outflow.
Premium access

Detailed competitors of Ivantis

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Sensors & Smart Devices

3 companies that operate in the same segment as Ivantis (Sensors & Smart Devices) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Smart fitness equipment and streaming platforms are provided.
2011New York, New York, United StatesUSD 995.53 MUSD 2.45 B2,894
VR-based head-mounted displays for gaming are provided by Oculus.
2012Menlo Park, California, United StatesUSD 107.05 M
Cloud-based business telephony and home security services are provided.
2004Palo Alto, California, United StatesUSD 87.97 MUSD 273.6 M1,190
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Ivantis

Premium access

Complete news archive for Ivantis

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ivantis

Ivantis was founded in 2007 and raised its 1st funding round 1 year after it was founded.

Ivantis is headquartered in Irvine, United States. It is registered at Irvine, California, United States.

Ivantis is a funded company, having raised a total of $166.23M across 7 funding rounds to date. The company's 1st funding round was a Series A of $19.1M, raised on Jun 2008.

Ivantis has 132 employees.

Ivantis Inc. was founded in 2007 in Irvine, United States, focusing on medical devices for ophthalmology. Solutions for primary open-angle glaucoma are developed by the company, including an intracanalicular scaffold designed as an implantable device. High intraocular pressures in patients are addressed through this technology. Operations center on innovation in glaucoma treatment, with the domain ivantisinc.com serving as the primary online presence.

Ivantis's top competitors include Glaukos, Myra Vision and Transcend Medical.

Ivantis has 11 investors. Key investors include Alcon, RA Capital, Merieux Equity Partners, NEA, and Delphi Ventures.

Ivantis operates through Ivantis, Inc..

Yes. Ivantis was acquired by Alcon in November 2021.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available